1748 / 1816
19-9-2017
Risk factors for cardiotoxicity
-Increased cumulative dose
-Age
-Predisposition cardiac
disease
-Meidastinal irradiation
-Hormonal therapy
-Risk factors cardiovasc.
disease
Risk of developing congestive heart
failure over 2.5 years after epirubicin
treatment
Ryberg M et al, JNCI 2008